|
|
 |
|
Viewing report
|
|
|
|
Global Cardiac Rhythm Management (CRM) Devices - Market Growth Analysis, 2009-2015
Axis Research Mind, Feb 2011, Pages: 700
Global Market Watch:
The broad ‘health care’ division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution of cardiac devices has opened new vistas in the health care industry. Growth rate exhibited by the cardiac devices industry, even during the recession years, confirms the positive growth prospects going ahead.
Global Cardiac Rhythm Management Devices (CRM) market forecasts to reach at US$22.3 billion by 2015 at a CAGR of 9.3% during the analysis period 2009-2015. The North American segment accounts for nearly 40% of the global value while Europe claims approximately 30% of the market. Asia-Pacific is the fastest growing region with a CAGR of 11.1% driving a market value of US$5.5 billion by 2015. On a global scale, projections for External Defibrillators market value indicate less than half of Implantable Cardioverter Defibrillators by 2015. External pacemaker’s market value forecasts show a 40% by 2015 leaving the rest of the market to the implantable pacemakers. Cardiac CRT devices market forecasts to reach at US$2.8 billion by 2015 at a CAGR of 10% during the analysis period and projections for CRT defibrillators market value suggest 45% by 2015 leaving the rest of the market to the CRT pacemakers and other similar devices.
Report Focus:
The report ‘Global Cardiac Rhythm Management (CRM) Devices - Market Growth Analysis, 2009-2015’ reviews the latest trends in the CRM devices market with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs), government organizations and many more in preferred locations. The report primarily focuses on:
- Emerging Market Trends
- Advancements in the Technological Space
- Market Demand Of The Segments (By-Region)
- Key Growth Areas and Market Size
- Region-Wise Demand Factor
- Key Competitors Edge
- Investment Strategies
The report covers the market analysis by product types. The subdivisions are as:
Cardiac Rhythm Management Devices
1.Cardiac Defibrillators
a.Implantable Cardioverter Defibrillators (ICD)
b.External Defibrillating Devices
2.Cardiac Pacemakers
a.Implantable Pacemakers (Single-Chamber Pacemakers and Dual-Chamber Pacemakers)
b.External Pacemakers
3.Cardiac Resynchronization Therapy (CRT)
a.Cardiac Resynchronization Therapy Defibrillator (CRT-D)
b.Cardiac Resynchronization Pacemakers (CRT-P)
c.Others
4.Surgical Ablation &
5.Others
The period considered for the study analysis is 2009-2015. The region wise distribution of the market consists of North America (USA and Canada), Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Belgium and Rest of Europe), Asia-Pacific (Japan, China, India, New Zealand, South Korea, Australia and Rest of Asia-Pacific), Latin America (Brazil, Argentina and Rest of Latin America) and Rest of World (South Africa, Middle East and Rest of Rest of World). Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.
More than 608 leading market players are identified and 82 key companies in cardiac medical devices industry that project improved market activities in the near future are profiled. The report consists of 408 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.
Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates. Estimates have incorporated recessionary impact on the cardiac devices industry. Anticipating a protracted recovery towards 2011, we have used CAGR to forecast 2011-2015 figures.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
